14 completed, 4 recruiting, 2 not yet recruiting, 1 terminated. 22 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Completed 14, Recruiting 4, Not yet recruiting 2, Terminated 1, Withdrawn 1 |
| Phase 2 | 4 | Not yet recruiting 2, Completed 1, Withdrawn 1 |
Follow Malaria, Vivax: new trials by email Literature Review of Malaria, Vivax trials Research Report on Malaria, Vivax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postpartum 8-aminoquinoline Breast Milk Study Daily primaquine (0.5 mg/kg per day) for 14 days given with food food and water, Daily primaquine 1 mg/kg per day for 7 days given with food and water, Single-dose tafenoquine given with food and water to prevent gastrointestinal discomfort - Drug Pharmacokinetics in Healthy Volunteers | Phase 2 / Phase 3 | Not yet recruiting | Curtin University | 60 | 2026-04-01 | 2026-03-18 |
| Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar PvSeroTAT, Control - Malaria Vivax, Malaria Falciparum | Phase 3 | Recruiting | London School of Hygiene and Tropical Medicine | 19200 | 2025-05-12 | 2026-09-18 |
| An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older Tafenoquine, Primaquine, Chloroquine - Malaria, Vivax | Phase 3 | Recruiting | GlaxoSmithKline | 324 | 2024-11-13 | 2026-10-01 |
| FocaL Mass Drug Administration for Vivax Malaria Elimination Focal Mass Drug Administration (fMDA) - Plasmodium Vivax Malaria, Malaria | Phase 3 | Recruiting | University of California, San Francisco | 7530 | 2024-10-14 | 2026-06-09 |
| Plasmodium Immunotherapy for Advanced Ovarian Cancer Plasmodium immunotherapy - Advanced Ovarian Cancer | Phase 2 / Phase 3 | Not yet recruiting | CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. | 30 | 2024-07-20 | 2024-07-22 |
| A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria Tafenoquine, Primaquine - Vivax Malaria | Phase 3 | Recruiting | Menzies School of Health Research | 1090 | 2024-05-10 | 2025-07-18 |
| Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia Primaquine double dose over 14 days, Primaquine single dose over 14 days - Malaria, Vivax, Relapse | Phase 2 / Phase 3 | Withdrawn | University of California, San Francisco | 2023-01-20 | 2023-05-11 | |
| Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine Tafenoquine, Primaquine - Vivax Malaria, Plasmodium Vivax | Phase 3 | Completed | Menzies School of Health Research | 960 | 2021-04-25 | 2024-10-08 |
| DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil CQ coadministered with PQ, DHA-PQP coadministered with PQ, CQ and PQ starting on Day 42 - Malaria, Vivax, Therapeutics | Phase 3 | Completed | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 419 | 2018-07-05 | 2023-06-12 |
| Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria Tafenoquine, Matched-Placebo for Tafenoquine, Primaquine - Malaria, Vivax | Phase 3 | Completed | GlaxoSmithKline | 150 | 2018-04-08 | 2020-07-24 |
| Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria Tafenoquine, Tafenoquine Placebo, Chloroquine - Malaria, Vivax | Phase 3 | Completed | GlaxoSmithKline | 251 | 2015-04-30 | 2018-05-16 |
| Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection Chloroquine, Primaquine - Malaria, Vivax | Phase 2 / Phase 3 | Completed | Oswaldo Cruz Foundation | 204 | 2014-08-01 | 2016-02-25 |
| Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD) Dihydroartemisinin-Piperaquine, Chloroquine - Vivax Malaria | Phase 3 | Completed | University of Oxford | 680 | 2012-02-01 | 2016-04-28 |
| Artemether/Lumefantrine and Vivax Malaria tablets artemether/lumefantrine - Vivax Malaria | Phase 3 | Completed | University of Khartoum | 38 | 2011-09-01 | 2013-01-17 |
| Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria Dihydroartemisinin/piperaquine + primaquine, Artesunate-amodiaquine + primaquine - Vivax Malaria | Phase 3 | Completed | University of Oxford | 331 | 2011-01-01 | 2013-08-29 |
| Study on the Treatment of Vivax Malaria Artesunate, Chloroquine, Chloroquine/Primaquine - Vivax Malaria | Phase 3 | Completed | University of Oxford | 655 | 2010-05-01 | 2013-08-28 |
| Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea chloroquine, sulphadoxine pyrimethamine, LLIN, azithromycin, sulphadoxine pyrimethamine, LLIN - Malaria in Pregnancy, Sexually Transmitted Infections | Phase 3 | Completed | University of Melbourne | 2793 | 2009-11-01 | 2013-04-23 |
| Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria Pyronaridine - artesunate, Chloroquine - Malaria | Phase 3 | Terminated | Medicines for Malaria Venture | 30 | 2007-09-06 | 2022-01-26 |
| A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan Dihydroartemisinin + Piperaquine (Artekin), artesunate-sulphadoxin/pyrimethamine, chloroquine - Uncomplicated Falciparum Malaria, Vivax Malaria | Phase 3 | Completed | University of Oxford | 1086 | 2007-07-01 | 2018-05-09 |
| Eight Week Primaquine Regimen for the Treatment of Vivax Malaria primaquine - Malaria, Vivax Malaria | Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 150 | 2004-04-01 | 2017-01-12 |
Showing 20 of 22. Sign in to see all of them.
Malaria (7) · Malaria, Falciparum (4) · Recurrence (3) · Anemia (1) · Breast Feeding (1) · Hemolysis (1) · Parasitic Diseases (1) · Sexually Transmitted Diseases (1) · Treponemal Infections (1)
Infections (22) · Mosquito-Borne Diseases (22) · Protozoan Infections (22) · Vector Borne Diseases (22) · Parasitic Diseases (21) · Malaria (15) · Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Behavior (1) · Communicable Diseases (1) · Feeding Behavior (1) · Genital Diseases (1)
Primaquine (12) · Chloroquine (9) · tafenoquine (6) · Artesunate (2) · artenimol (2) · fanasil, pyrimethamine drug combination (2) · piperaquine (2) · Amodiaquine (1) · Artemether (1) · Azithromycin (1) · Food (1) · Lumefantrine (1) · Pyrimethamine (1) · Water (1) · amodiaquine, artesunate drug combination (1)
London School of Hygiene and Tropical Medicine (4) · University of Oxford (4) · GlaxoSmithKline (3) · Menzies School of Health Research (2) · University of California, San Francisco (2) · CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. (1) · Curtin University (1) · Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (1) · Medicines for Malaria Venture (1) · Oswaldo Cruz Foundation (1) · University of Khartoum (1) · University of Melbourne (1)
Brazil (4) · Ethiopia (4) · Indonesia (4) · Pakistan (3) · Papua New Guinea (3) · Thailand (3) · Peru (2) · Afghanistan (1) · Cambodia (1) · China (1) · Colombia (1) · India (1) · Madagascar (1) · South Korea (1) · Sudan (1)
Francois Nosten, MD (2) · Mark Rowland, PhD (2) · Alejandro Llanos-Cuentas, MD, PhD (1) · Ayodhia Pitaloka Pasaribu, MD (1) · Brioni Moore, PhD (1) · Chris Drakeley (1) · Christopher Whitty, FRCP (1) · Cindy Chu, MD (1) · Fitsum G Tadesse (1) · Ghulam R Awab, MD (1) · Guo Shuiqun, Ph.D., M.D. (1) · Kamala N Thriemer, PhD (1) · Kamala Thriemer, MD, MPH, PhD (1) · Kate Graham, MSc (1)
PMID 36534705, PMID 17519409, PMID 18682739, PMID 20409302, PMID 22427705, PMID 23217037, PMID 23926329, PMID 25591391, PMID 26006260, PMID 26286026, PMID 26917051, PMID 28103875, PMID 28170391, PMID 29889239, PMID 30650326, PMID 30782991, PMID 30952158, PMID 34181872, PMID 34398667, PMID 34607575, PMID 35619134, PMID 37236221, PMID 40321759, PMID 41088393, PMID 41690325, PMID 42114535, PMID 42575554
U01AI157962 (1)